LITHIUM, ELEMENTAL
Recurrent Malignant Testicular Germ Cell Tumor
Fred Hutchinson Cancer CenterSmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Recurrent Malignant Testicular Germ Cell Tumor cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
CIS-DIAMMINEDICHLOROPLATINUM II Children's Oncology Group | Phase 3 | BB |
CALCIUM PHOSPHATE Children's Oncology Group | Phase 3 | BB |
ETOPOSIDE Roswell Park Cancer Institute | Phase 3 | BB |
Carboplatin Children's Oncology Group | Phase 2 | BB |
BLEOMYCIN Children's Oncology Group | Phase 3 | BB |
View all 31 →
Same molecule, other indications
LITHIUM, ELEMENTAL is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →